Mouse monoclonal antibody against human CD3 antigen of T lymphocyte (Wuhan Institute of Biological Products)

抗人T细胞CD3鼠单抗（武汉生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMouse monoclonal antibody against human CD3 antigen of T lymphocyte (Wuhan Institute of Biological Products)
Drug Alias Nameanti-CD3 mouse monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionT cell surface glycoprotein CD3 inhibitors
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsRejection of organ transplantation
Approved Indications in ChinaRejection of organ transplantation
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A